Indivior Pharmaceuticals, Inc. (INDV) · Nov 3, 2026 · Other events

Supernus convertible notes reset after special dividend, no conversions

Conversion terms reset — 24.0033→30.9355 shares per $1,000; no conversions

Supernus disclosed a mechanical convertible-note adjustment following Indivior’s special dividend. The reset changes dilution terms, not the combined company’s operating story.

Supernus is now the combined Indivior–Supernus CNS company following the merger completed on November 2, 2026, with a broader marketed portfolio, pipeline, and expected cost synergies. This filing is a mechanical post-dividend adjustment, not a new business development. The $1 billion special dividend was already announced and tied to the merger closing, so the note reset was an expected consequence rather than fresh information.

Note termsFiling figureComparison
Coupon (Notes)0.625%2031 maturity
Conversion rate (Notes)30.9355 shares per $1,000 (Financial terms)24.0033 previously
Conversion price (Financial terms)$32.33 per share—

The adjustment mainly reallocates potential dilution between shareholders and bondholders. The conversion rate rises from 24.0033 to 30.9355 shares per $1,000, reflecting the special dividend under the indenture. That gives noteholders a lower effective conversion price after the cash distribution, but it does not raise new capital or change the combined company’s operating plan.

There is no immediate dilution from this notice. The filing says no bondholders converted their notes into common stock. 〔0〕 The adjustment therefore changes the potential future share count, while leaving current ownership and operations untouched.

Bottom line: This is routine merger-and-dividend plumbing, not a change to Supernus’s business trajectory. It confirms the expected noteholder protection mechanism and adds no new operating signal.

Original filing on SEC EDGAR

More Indivior Pharmaceuticals, Inc. news

Supernus convertible notes reset after special dividend, no conversions | INDV Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.